Ameya Puranik
8PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 29, 2025
PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs).Ameya D Puranik, Indraja D Dev, Sushil Yadav
|Feb 17, 2025
Frontiers in radiopharmaceuticals for neuroendocrine tumors.Ameya D Puranik, Indraja D Dev, Vikas Prasad
|Nov 11, 2024
FET PET to differentiate between post-treatment changes and recurrence in high-grade gliomas: a single center multidisciplinary clinic controlled study.Ameya D Puranik, Indraja D Dev, Venkatesh Rangarajan
|Apr 28, 2023
Imaging-Based Patterns of Failure following Re-Irradiation for Recurrent/Progressive High-Grade Glioma.Debanjali Datta, Archya Dasgupta, Abhishek Chatterjee
|Jan 27, 2023
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.Vijay Maruti Patil, Vanita Noronha, Nandini Menon
|Oct 20, 2022
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study.Vijay Maruti Patil, Vanita Noronha, Nandini Menon
Pageof 2
Frequent Collaborators
2 joint publications
Vanita Noronha
2 joint publications
Nandini Menon
2 joint publications
Atanu Bhattacharjee
2 joint publications
Mitali Alone
2 joint publications
Archi Agarwal
2 joint publications
Kumar Prabhash
1 joint publications
Mike Sathekge
1 joint publications
Michael Grunert
1 joint publications
Vijay Maruti Patil
1 joint publications
Neha Mittal
